Tensions have risen between White House officials and HHS Secretary Alex Azar; a life-saving bladder cancer drug is in short supply; suicide rates for children and young adults have soared.
Tensions have widened the rift between White House officials and HHS Secretary Alex Azar, POLITICO reported, resulting in impeded projects, disputes over Medicaid and fetal tissue research, complicating drug pricing reform, and spurring personal attacks, according to current and former White House aides and HHS officials. The White House called the disagreements part of the deliberative policy process while HHS downplayed the disputes. Azar is believed not to be at risk of being fired despite the recent tensions.
While drug shortages are sometimes caused by production errors, quality problems, and natural disasters, the example of a low-cost, gold standard immunotherapy drug for bladder cancer illustrates another reason—some believe the price is set too low and discourage others from making the off-patent drug. Desperate patients are searching for a Merck drug, called BCG, a live, weakened bacteria that takes 3 months to make, The Washington Post reported.
A study in JAMA found that suicide rates for teens and young adults have reached the highest level since 2000, especially for young men, while the rate for females steadily increased. A total of 5016 males and 1225 females between 15 to 24 years old took their own lives in 2017. At ages 15 to 19 years, the rate of suicides was 11.8 per 100,000 (17.9 per 100,000 in males and 5.4 per 100,000 in females). In young adults aged 20 to 24 years, the suicide rate for males and females combined in 2017 was 17 per 100,000; in males, 27.1 per 100,000; and in females, 6.2 per 100,000.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More